(Q38271890)

1 September 2017

1 reference

title

Ferric carboxymaltose: a review of its use in iron deficiency (English)

1 reference

1 September 2017

1

Gillian M Keating

1 reference

1 September 2017

publication date

1 January 2015

1 reference

1 September 2017

1 reference

1 September 2017

volume

75

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

101-127

1 reference

Iron deficiency anemia in heart failure

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Guidelines for the management of iron deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Expert recommendations for the diagnosis and treatment of iron-deficiency anemia during pregnancy and the postpartum period in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Systemic iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Iron deficiency syndromes and iron-restricted erythropoiesis (CME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Iron deficiency anaemia: a review of diagnosis, investigation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Non-transferrin bound iron: a key role in iron overload and iron toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Treatment of Iron Deficiency with or without Anaemia with Intravenous Ferric Carboxymaltose in Gynaecological Practices - A Non-Interventional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Intravenous ferric carboxymaltose for anaemia in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage--a placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Cost-utility of ferric carboxymaltose (Ferinject®) for iron-deficiency anemia patients with chronic heart failure in South Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

UK guidelines on the management of iron deficiency in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Perioperative anemia management in colorectal cancer patients: a pragmatic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Intravenous iron in heart failure: beyond targeting anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Intravenous iron therapy in non-dialysis CKD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Intravenous iron in inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Perioperative anaemia management: consensus statement on the role of intravenous iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

From bloodless surgery to patient blood management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Ferric carboxymaltose with or without erythropoietin for the prevention of red-cell transfusions in the perioperative period of osteoporotic hip fractures: a randomized contolled trial. The PAHFRAC-01 project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

FAIRY: a randomized controlled patient-blind phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose (Ferinject®) to placebo in patients with acute isovolemic anemia after gastrectomy - study protocol for a randomized

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Transfusion strategies for acute upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-014-0332-3

A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery

21 January 2018

1 reference

12 December 2020

Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency

1 reference

12 December 2020

Iron, oxidative stress, and clinical outcomes

1 reference

12 December 2020

Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial

1 reference

12 December 2020

Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients

1 reference

12 December 2020

Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials

1 reference

12 December 2020

Severe hypophosphataemia after intravenous iron administration

1 reference

12 December 2020

Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.

1 reference

12 December 2020

Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure

1 reference

12 December 2020

Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials

1 reference

12 December 2020

New strategies for managing anemia of chronic kidney disease

1 reference

12 December 2020

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

1 reference

12 December 2020

An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic

1 reference

12 December 2020

Structure/histotoxicity relationship of parenteral iron preparations

1 reference

12 December 2020

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

1 reference

12 December 2020

Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease

1 reference

12 December 2020

What is the optimal treatment for anemia in inflammatory bowel disease?

1 reference

12 December 2020

Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia

1 reference

12 December 2020

A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

1 reference

12 December 2020

Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study

1 reference

12 December 2020

Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial

1 reference

12 December 2020

Review on iron and its importance for human health

1 reference

12 December 2020

Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose

1 reference

12 December 2020

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.

1 reference

12 December 2020

Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial

1 reference

12 December 2020

Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients

1 reference

12 December 2020

Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: The German AnaemIBD Study

1 reference

12 December 2020

Effects of intravenous iron on mononuclear cells during the haemodialysis session

1 reference

12 December 2020

The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose

1 reference

12 December 2020

In vitro studies of ferric carboxymaltose on placental permeability using the dual perfusion model of human placenta

1 reference

12 December 2020

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

1 reference

12 December 2020

10.1007/S40265-014-0332-3

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1016659237

0 references

1 reference